Cargando…
The risk of dyspnea in patients treated with third-generation P2Y(12) inhibitors compared with clopidogrel: a meta-analysis of randomized controlled trials
BACKGROUND: Ticagrelor and prasugrel are two third-generation oral P2Y(12) inhibitors which are more commonly used in clinical practice. However, dyspnea has been consecutively reported in patients using third-generation oral P2Y(12) inhibitors. This study aims to compare the risk of dyspnea in pati...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079377/ https://www.ncbi.nlm.nih.gov/pubmed/32183711 http://dx.doi.org/10.1186/s12872-020-01419-y |